uniQure QURE
NASDAQ QURE
$44.50 -0.36 (-0.80%)
As of: Sep 4, 2026 · 3:59 PM EDT

uniQure (QURE) Capital Expenditures (2016 - 2026)

uniQure (QURE) posted quarterly Capital Expenditures of $472000.0 for Q2 2026, up 81.54% year-over-year from $260000.0 in Q2 2025, and up 237.14% quarter-over-quarter from $140000.0 in Q1 2026.

Analysis

uniQure (QURE) Capital Expenditures (2016 - 2026) Analysis & Trends

uniQure's Capital Expenditures history runs 11 years deep, the most recent figure standing at $472000.0 for Q2 2026.

  • In Q2 2026, Capital Expenditures rose 81.54% year-over-year to $472000.0; the TTM figure through Jun 2026 stood at $665000.0 (down 17.49% YoY), while the FY2025 annual figure was $439000.0, down 86.97% from the prior year.
  • Capital Expenditures for Q2 2026 stood at $472000.0, up from $140000.0 in the prior quarter.
  • The five-year high for Capital Expenditures was $5.1 million in Q4 2022, with the low at -$66000.0 in Q3 2025.
  • The 5-year median for Capital Expenditures is $839000.0 (2023), against an average of $1.6 million.
  • Peak annual rise in Capital Expenditures reached 197.5% in 2025, while the deepest fall reached 117.37% in 2025.
  • uniQure's Capital Expenditures stood at $5.1 million in 2022, then plunged by 59.77% to $2.0 million in 2023, then sank by 98.04% to $40000.0 in 2024, then surged by 197.5% to $119000.0 in 2025, then jumped by 296.64% to $472000.0 in 2026.
  • Business Quant data shows QURE's Capital Expenditures at $472000.0 in Q2 2026, $140000.0 in Q1 2026, and $119000.0 in Q4 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Capital Expenditures (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn 112.20 Mn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn 240.20 Mn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn -
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn 37.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn - 2.29 Mn
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 25.02 Mn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn 34.68 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn - 251.02 Mn
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn 6.26 Mn
10 uniQure 2.95 Bn 2.95 Bn 5.49 Mn 472,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 472,000.00
Mar 31, 2026 140,000.00
Dec 31, 2025 119,000.00
Sep 30, 2025 -66,000.00
Jun 30, 2025 260,000.00
Mar 31, 2025 126,000.00
Dec 31, 2024 40,000.00
Sep 30, 2024 380,000.00
Jun 30, 2024 604,000.00
Mar 31, 2024 2.34 Mn
Dec 31, 2023 2.04 Mn
Sep 30, 2023 1.70 Mn
Jun 30, 2023 1.07 Mn
Mar 31, 2023 2.34 Mn
Dec 31, 2022 5.07 Mn
Sep 30, 2022 3.99 Mn
Jun 30, 2022 4.58 Mn
Mar 31, 2022 4.06 Mn
Dec 31, 2021 3.55 Mn
Sep 30, 2021 7.69 Mn